Eleven Biotherapeutics (NASDAQ: EBIO), a clinical-stage
biopharmaceutical company discovering and developing protein
therapeutics to treat diseases of the eye, today reported financial
results for the third quarter ended September 30, 2014 and recent
Wal-Mart Stores Inc. (WMT) shares rose 2% in premarket trade on Thursday after its third-quarter profit and sales topped Wall Street expectations and Walmart U.S. unit reported better-than-expected same-store sales.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.